The main question in this paper was to look at the distribution of auxotypes and serovars of Neisseria gonorrhoeae and check whether they correlate with clinical symptoms/signs among female sex workers (FSW) from Kinshasa, Zaire. The subjects were 1233 FSW enrolled in a cross sectional study on STDs and HIV infection in 1988; 771 of them were followed prospectively for a median duration of 23 months. At each visit, clinical symptoms and signs of cervicitis were recorded and the subjects were screened for gonococcal and chlamydial infection. The predominant auxotypes were prototrophic (35 2%), proline requiring (29.6%), and proline requiring phenylalanine inhibition (19%). Serovars 1A-6 (42.5%) and lB-i (1 6.7%) were the commonest. Infection with auxotype prototrophic and phenylalanine inhibition (Proto/Phenali) was significantly associated with both mucopurulent cervicitis and pelvic inflammatory disease; (OR = 8.9; p = 0002 and OR = 19.9; p = 0.002; respectively). Despite the few associations found in this study, there was no clear pattern linking clinical manifestations to auxotype/serovar profiles.
Introduction
It is well known that the epidemiology of Neisseria gonorrhoeae infection is influenced by auxotypes and serovars that are structurally and antigenically different.' 2 Combining the two classification systems, a total of 63 distinct auxotype/serovar classes were identified. The prevalence of the majority of these classes remained stable over the study period with the exception of Proto/lB-7 and Pro/lA-6 classes that had changed dramatically in the second 6 months. The former was increased by a factor of 5 (from 4x6% to 23x6%; p < 0.01) and the second decreased very significantly (from 26.1% to 106%; p < 0.01). 
Discussion
Our data show that the most frequent auxotypes were prototrophic and proline requiring. We noticed that the predominance of these two auxotypes was also reported elsewhere in Africa (Gabon) and in several studies performed in America and Europe.5 8 However, auxotypes Arg-Hyp-Ura-and Pro-Cit Ura-Hypx-which have been isolated in Europe and America were not isolated in our study population. We also found auxotype Pro-Phenali very frequent (19%). This auxotype was not isolated in other studies of which we are aware since strains were not tested for the inhibitory activity of phenylalanine. In industrialised countries, the serovars of serogroup B seem to predominate whereas in our study, as in Gabon, more than half of the strains were serogroup A. Indeed, in Spain, serovars of serogroup B accounted for 93.5% of all strains.8 This serogroup also predominated in Canada (66'8%) and in Sweden (70%).2 9 We observed dramatic changes in the gonococcal population infecting the cohort over the study period with the introduction of new strains and loss of other strains. This has been previously reported.3 The significant loss of certain strains supports the notion of gonococcal strain specific acquired (partial) immunity, as proposed by Plummer and colleagues who reported that women experiencing an infection with a specific gonococcal serovar were at 2-to 10-fold reduced risk of reinfection with the same strain. 10 Despite the fact we made multiple comparisons, we found that only a few auxotypes/ serovars of N gonorrhoeae were significantly associated with clinical manifestations of gonococcal infection and the strength of some associations may suggest that they did not occur by chance only. Indeed, we found that auxotype Proto/Phenali was strongly associated with both MPC and PID. However, this apparently increased virulence of auxotype Proto/Phenali should be interpreted with caution because of the small number of women infected with this strain (only 11 of the 622 auxotypes) and the impossibility of comparing our results with those reported by other authors since this auxotype was not isolated in their studies.
In summary, we did not identify many associations between auxotypes/serovars of N gonorrhoeae and symptoms/signs. To compare the associations we observed and to obtain a better understanding of the epidemiology of gonococcal infection in developing countries, there is a need for additional studies using similar methods distinguishing between strains of N gonorrhoeae (including testing for phenylalanine inhibition) in areas where the same isolates can be found.
